← Back to Clinical Trials
Recruiting NCT06834906

NCT06834906 Usability User Testing of the Easy-EyeFM AI Platform

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06834906
Status Recruiting
Phase
Sponsor Tsinghua University
Condition Ocular Diseases
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2025-01-26
Primary Completion 2025-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
EasyEyeFM-AutoML-AI-platform testAutoML-EasyEyeFM-AI-platform test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 84 participants in total. It began in 2025-01-26 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Easy-EyeFM is a code-free artificial intelligence platform designed for ophthalmologists to provide diagnostic and treatment recommendations and help doctors develop customized diagnostic models. This project aims to evaluate the usability and user-friendliness of the Easy-EyeFM platform for physicians. The study will gather feedback from medical professionals to evaluate the intuitiveness and effectiveness of the platform in supporting model customization and medical image analysis tasks. Subjects will participate in the trial of the Easy-EyeFM platform and the comparison with the existing commercial platform (AutoML) at the appointed time. The researchers will inform subjects of relevant precautions and assist them to read the user manual before the test. Subjects will complete model customization and picture diagnosis within the prescribed test time, and according to the test results, Score the human-computer interaction experience of the AI platform, fill in the questionnaire, and finally complete the evaluation content.

Eligibility Criteria

Inclusion Criteria: * Medical students or doctors * Have enough time to participate in this program, about 1 hour continuous assessment * Agree to sign the informed consent form Exclusion Criteria: * Poor computer and mobile phone use and reading ability * Poor language expression or dialect category is not included in the speech recognition function of the platform

Contact & Investigator

Central Contact

Jinyuan Wang

✉ jinyuanwang@tsinghua.edu.cn

📞 086-15801191316

Principal Investigator

Tien Yin Wong

PRINCIPAL INVESTIGATOR

Tsinghua University

Frequently Asked Questions

Who can join the NCT06834906 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Ocular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06834906 currently recruiting?

Yes, NCT06834906 is actively recruiting participants. Contact the research team at jinyuanwang@tsinghua.edu.cn for enrollment information.

Where is the NCT06834906 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06834906 clinical trial?

NCT06834906 is sponsored by Tsinghua University. The principal investigator is Tien Yin Wong at Tsinghua University. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology